Abstract
Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by chronic or recurrent abdominal pain/discomfort, altered bowel function (urgency, altered stool consistency, altered stool frequency, incomplete evacuation), and bloating/distention. These symptoms are felt to stem from the function of the bowels. They are not explained by identifiable structural or biochemical abnormalities. The two most commonly used symptombased criteria for IBS are the Manning criteria (Manning, Thompson, Heating, & Morris, 1978) and the Rome criteria (Thompson et al., 2000; Thompson et al., 1999). These criteria were originally developed for adults, but have been successfully used with children and adolescents. The Manning criteria were established to differentiate IBS from organic disease in patients attending an outpatient gastroenterology clinic. They have been used for patient selection in epidemiological studies and clinical trials and have served their original purpose well. The Manning criteria include the following: (1) visible abdominal distention, (2) relief of pain with bowel movement, (3) more frequent bowel movements with the onset of pain, (4) loose stools at onset of pain, (5) passage of mucous per rectum, and (6) feeling of incomplete evacuation. The Rome criteria resulted from consensus conferences to define criteria for a broad range of functional gastrointestinal disorders. The most recent version, the Rome II criteria (Rasquin-Weber et al., 1999), have emerged as the gold standard and require that the primary IBS symptoms must be continuous or recurrent for at least 3 months. The abdominal pain or discomfort has two or three features: (1) it is relieved with defecation, (2) associated with a change in frequency of stool, and/or (3) associated with a change in form of stool. No structural or metabolic abnormalities explain the symptoms. According to Rome II criteria, symptoms that cumulatively support the diagnosis of IBS include: abnormal stool frequency (> 3 BMs/day or < 3 BMs/week); abnormal stool form (lumpy/hard or loose/watery stool); abnormal stool passage (straining, urgency, or feeling of incomplete evaluation); passage of mucous; and bloating or feeling of abdominal distention. When appropriate, the Rome II criteria classify IBS as either “diarrhea-predominant” or “constipation-predominant” on the basis of the predominant bowel habit. For some individuals, diarrhea and constipation alternate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Achenbach, T. M. (1991). Manual for the Child Behavior Checklist 14–18 and 1991 Profile. Burlington, VT: University of Vermont Department of Psychiatry.
American Digestive Health Foundation. (2001). Irritable bowel syndrome: Part 1: Nosology, epidemiology, and pathophysiology. Bethesda, MD: American Digestive Health Foundation.
Bennett, E. J., Tennant, C. C., Piesse, C., Badcock, C-A., & Kellow, J. E. (1998). Level of chronic life stress predicts clinical outcome in irritable bowel syndrome. Gut, 43, 256–261.
Blanchard, E. B., & Scharff, L. (2002). Psychosocial aspects of assessment and treatment of irritable bowel syndrome in adults and recurrent abdominal pain in children. Journal of Consulting and Clinical Psychology, 70, 725–738.
Blanchard, E. B., & Schwarz, S. P. (1987). Adaptation of a multicomponent treatment program for irritable bowel syndrome to a small group format. Biofeedback, 12, 63–69.
Collins, S. M. (1999). Natural history and prognosis. In R. Stockbrugger, & F. Pace (Eds.), The irritable bowel syndrome manual (pp. 81–86). London, UK: Mosby-Wolfe.
Compas, B. E., Davis, G. E., Forsythe, C. J., & Wagner, B. M. (1987). Assessment of major and daily life events during adolescence: The Adolescent Perceived Events Scale. Journal of Consulting and Clinical Psychology, 55, 534–541.
Connor-Smith, J. K., Compas, B. E., Wadsworth, M. E., Thomsen, A. H., & Saltzman, H. (2000). Responses to stress in adolescence: Measurement of coping and involuntary stress responses. Journal of Consulting and Clinical Psychology, 68, 976–992.
Cox, D. J., Sutphen, J., Borowitz, S., Kovatchev, B., & Ling, W. (1998). Contribution of behavior therapy and biofeedback to laxative therapy in the treatment of pediatric encopresis. Annals of Behavioral Medicine, 20, 70–76.
Drossman, D. A. (1998). Presidential address: Gastrointestinal illness and the biopsychosocial model. Psychosomatic Medicine, 60, 258–267.
Drossman, D. A. (1999). An integrated approach to the irritable bowel syndrome. Aliment Pharmacology Therapy, 13(Suppl. 2), 3–14.
Drossman, D. A., & Thompson, G. (1992). The irritable bowel syndrome: Review and a graduated multicomponent approach. Annals of Internal Medicine, 116, 1009–1016.
Drossman, D. A., Toner, B. B., Whitehead, W. E., Diamant, N. E., Dalton, C. B., Duncan, S., Emmott, S., Proffitt, V. Akman, D., Frusciante, K., Le, T., Meyer, K., Bradshaw, B., Mikula, K. Morris, C. B., Blackman, C. J., Hu, Y., Jia, H., Li, J. Z., Koch, G. G., Bangdiwala, S. I. (2003). Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders. Gastroenterology, 25, 249–253.
Drossman, D. A., Whitehead, W. E., & Camilleri, M. (1997). Irritable bowel syndrome: A technical review for practice guideline development. Gastroenterology, 112, 2120–2137.
Drossman, D. A., Zhiming, L., Andruzzi, E., Temple, R. D., Talley, N. J., Thompson, W. G., Whitehead, W. E., Janssens, J., Funch-Jensen, P., Corazziari, E., & Richter, J. E. (1993). U. S. Householder Survey of Functional Gastrointestinal Disorders: Prevalence, Sociodemography, and Health Impact. Digestive Diseases and Sciences, 38, 1569–1580.
Everhart, J. E., & Renault, P. F. (1991). Irritable bowel syndrome in office-based practice in the United States. Gastroenterology, 100, 998–1005.
Finney, J.W., Lemanek, K. L., Cataldo, M. F., Katz, H. P., & Fuqua, R.W. (1989). Pediatric psychology in primary health care: Brief targeted therapy for recurrent abdominal pain. Behavior Therapy, 20, 283–291.
Galovski, T. E., & Blanchard, E. B. (1998). The treatment of irritable bowel syndrome with hypnotherapy. Applied Psychophysiology and Biofeedback, 23, 219–232.
Gaynes, B. N., & Drossman, D. A. (1999). The role of psychosocial factors in irritable bowel syndrome. Balliere’s Clinical Gastronenterology, 13, 437–452.
Guthrie, E., Creed, F., Dawson, D., Tomenson, B. (1993). A randomised controlled trial of psychotherapy in patients with refractory irritable bowel syndrome. British Journal of Psychiatry, 163, 315–321.
Hahn, B. A., Yan, S., & Strassels, S. (1999). Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion, 60, 77–81.
Harvey, R. F., Hinton, R. A., Gunary, R. M., & Barry, R. E. (1989). Individual and group hypnotherapy in treatment of refractory irritable bowel syndrome. Lancet, I, 424–425.
Hyams, J. S. (1999). Chronic and recurrent abdominal pain. In P. E. Hyman (Ed.), Pediatric functional gastrointestinal disorders (pp. 7.1–7.21). New York: Academic Professional Information Services.
Hyams, J. S., Burke, G., Davis, P. M., Rzepski, B., & Andrulonis, P. A. (1996). Abdominal pain and irritable bowel syndrome in adolescents: A community-based study. Journal of Pediatrics, 129, 220–226.
Hyams, J. S., Treem, W. R., Justinich, C. J., Davis, P., Shoup, M., & Burke, G. (1995). Characterization of symptoms in children with recurrent abdominal pain: Resemblance to irritable bowel syndrome. Journal of Pediatric Gastroenterology and Nutrition, 20, 209–214.
International Foundation for Functional Gastrointestinal Disorders (IFFGD). (2002). IBS in the real world survey: Summary findings. Milwaukee: Author.
Jailwala, J., Imperiale, T. F., & Kroenke, K. (2000). Pharmacological treatment of the irritable bowel syndrome: A systematic review of randomized, controlled trials. Annals of Internal Medicine, 133, 136–147.
Manning, A. P., Thompson, W. E., Heaton, K. W., & Morris, A. F. (1978). Towards a positive diagnosis of the irritable bowel. British Medical Journal, 2, 653–654.
Neff, D. F., & Blanchard, E. B. (1987). A multi-component treatment for irritable bowel syndrome. Behaviour Therapy, 18, 70–83.
Physician Drug and Diagnosis Audit (PDDA). (1999). Newton, PA: Scott-Levin PMSI Inc.
Rasquin-Weber, A., Hyman, P. E., Cucchiara, S., Fleisher, D., R., Hyams, J. S., Milla, P. J. et al. (1999). Childhood functional gastrointestinal disorders. Gut, 45(Suppl. II), II60–II68.
Sanders, M. R., Rebgetz, M., Morrison, M., Bor, W., Gordon, A., Dadds, M. et al. (1989). Cognitive-behavioral treatment of recurrent nonspecific abdominal pain in children: An analysis of generalization, maintenance, and side effects. Journal of Consulting and Clinical Psychology, 57, 294–300.
Sandler, R. S. (1990). Epidemiology of irritable bowel syndrome in the Unitedn States. Gastroenterology, 99, 409–415.
Stark, L. J., Opirari, L. C., Donaldson, D. L., Danovsky, M. B., Rasile, D. A., & DelSanto, A. F. (1997). Evaluation of a standard protocol for retentive encopresis. Journal of Pediatric Psychology, 22, 619–633.
Svedlund, J., Sjodin, I., Ottosson, J. O., & Dotevall, G. (1983). Controlled study of psychotherapy in irritable bowel syndrome. Lancet, 2, 589–592.
Svendsen, J. H., Munck, L. K., & Andersen, J. R. (1985). Irritable bowel syndrome prognosis and diagnostic safety: A 5-year follow-up study. Scandinavian Journal of Gastroenterology, 20, 415–418.
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K. W., Irvine, E. J., & Muller-Lissner, S. A. (1999). Functional bowel disorders and functional abdominal pain. Gut, 45, 1143–1147.
Thompson, W. G., Longstreth, G. F., Drossman, D. A., Heaton, K., Irvine, E. J., & Muller-Lissner, S. (2000). Functional bowel disorders and functional abdominal pain. In D. A. Drossman, E. Corraziari, N. J. Talley, & W. E. Whitehead (Eds)., Rome II. The functional gastrointestinal disorders: Diagnosis, pathophysiology, and treatment — A multinational consensus (2nd ed., pp. 351–432). McLean, VA: Degnon Associates.
Walker, L. S., & Greene, J. W. (1991). The Functional Disability Inventory: Measuring a neglected dimension of child health status. Journal of Pediatric Psychology, 16, 39–58.
Walker, L. S., Guite, J. W., Duke, M., Barnard, J. A., & Greene, J. W. (1998). Recurrent abdominal pain: A potential precursor of irritable bowel syndrome in adolescents and young adults. Journal of Pediatrics, 132, 1010–1015.
Walker, L. S., & Zeman, J. L. (1992). Parental response to child illness behavior. Journal of Pediatric Psychology, 17, 49–71.
Wells, N. E., Hahn, B. A., & Whorwell, P. J. (1997). Clinical economics review: Irritable bowel syndrome. Alimentary Pharmacology and Therapeutics, 11, 1019–1030.
Whitehead, W. E., Levy, R. L., Von Korff, M., Feld, A. D., Palsson, O. S., Turner, M., & Drossman, D. A. (2004). The usual medical care for irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 20, 1305–1315.
Whorwell, P. J., Prior, A., & Colgan, S. M. (1987). Hypnotherapy in severe irritable bowel syndrome: Further experience. Gut, 28, 423–425.
Whorwell, P. J., Prior, A., & Faragher, E. B. (1984). Controlled trial of hypnotherapy in the treatment of refractory irritable bowel syndrome. Lancet, 1232–1234.
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
(2006). Irritable Bowel Syndrome. In: Pediatric Gastrointestinal Disorders. Springer, Boston, MA. https://doi.org/10.1007/0-387-25612-1_7
Download citation
DOI: https://doi.org/10.1007/0-387-25612-1_7
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-25611-5
Online ISBN: 978-0-387-25612-2
eBook Packages: Behavioral ScienceBehavioral Science and Psychology (R0)